newsfilter
← Latest News
GlobeNewswire·

Beneficient Closes $7.44 Million GP Primary Capital Transaction

  • Beneficient closed a $7.44 million primary capital commitment in Quartus AI Fund II LP, an AI-focused fund managed by Quartus Capital Partners LLC.
  • Consideration for the commitment was approximately $7.44 million in Resettable Convertible Preferred Stock, which is convertible into Class A common stock at the holder's election.
  • The commitment scales with the Fund's total capital up to $26.25 million if the Fund achieves its $150 million target.
  • The Transaction adds approximately $7.44 million to Beneficient's ExAlt loan portfolio collateral & increases tangible book value by $7.44 million.
  • This marks Beneficient's second GP primary capital transaction this year, contributing $17.2 million in aggregate tangible book value year-to-date.
  • Quartus AI Fund II LP targets growth-stage AI companies with at least $5 million in commercial revenue across sectors including HealthTech, EdTech, Physical AI, World Models, LegalTech, Logistics, & Safety.
  • Beneficient's GP Primary Commitment Program aims to satisfy up to $330 billion in potential demand for primary commitments to meet fundraising needs.
  • A preliminary proxy statement will be filed with the SEC to seek stockholder approval for the issuance of Class A common stock upon conversion of the Preferred Stock.
  • Beneficient's Class A common stock closed at a price implying a market capitalization of $50,646 thousand as of July 10, 2026.